Your browser doesn't support javascript.
loading
PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy.
Jacot, William; Dalenc, Florence; Lopez-Crapez, Evelyne; Chaltiel, Leonor; Durigova, Anna; Gros, Nathalie; Lozano, Nicolas; Lacaze, Jean-Louis; Pouderoux, Stéphane; Gladieff, Laurence; Romieu, Gilles; Roché, Henri; Filleron, Thomas; Lamy, Pierre-Jean.
Afiliación
  • Jacot W; Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), Univ. Montpellier, 208 rue des Apothicaires, 34298, Montpellier Cedex 5, France. William.Jacot@icm.unicancer.fr.
  • Dalenc F; Translational Research Unit, Institut du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France. William.Jacot@icm.unicancer.fr.
  • Lopez-Crapez E; INSERM, U1194, Montpellier, France. William.Jacot@icm.unicancer.fr.
  • Chaltiel L; Department of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
  • Durigova A; Translational Research Unit, Institut du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France.
  • Gros N; INSERM, U1194, Montpellier, France.
  • Lozano N; Department of Biostatistics, Institut Claudius Regaud, IUCT-O, Toulouse, France.
  • Lacaze JL; Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), Univ. Montpellier, 208 rue des Apothicaires, 34298, Montpellier Cedex 5, France.
  • Pouderoux S; Translational Research Unit, Institut du Cancer de Montpellier (ICM), Univ. Montpellier, Montpellier, France.
  • Gladieff L; Institut d'Analyse Génomique, Imagenome-Inovie, Clinique BeauSoleil, Montpellier, France.
  • Romieu G; Department of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
  • Roché H; Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), Univ. Montpellier, 208 rue des Apothicaires, 34298, Montpellier Cedex 5, France.
  • Filleron T; Department of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France.
  • Lamy PJ; Department of Medical Oncology, Institut du Cancer de Montpellier (ICM), Univ. Montpellier, 208 rue des Apothicaires, 34298, Montpellier Cedex 5, France.
Breast Cancer Res Treat ; 177(3): 659-667, 2019 Oct.
Article en En | MEDLINE | ID: mdl-31297647
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biomarcadores de Tumor / Fosfatidilinositol 3-Quinasa Clase I / ADN Tumoral Circulante / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2019 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biomarcadores de Tumor / Fosfatidilinositol 3-Quinasa Clase I / ADN Tumoral Circulante / Mutación Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2019 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Países Bajos